APO RESEARCH · REPORT
Erythropoietin
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Product & engineering
Understand the product.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
Selected research
Market Structure
Global Erythropoietin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
Read the full market overview
The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.
This report provides an overview of the global Erythropoietin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Erythropoietin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Erythropoietin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Erythropoietin market size, projected growth trends, production technologies, key applications, and end-use industries.
Erythropoietin Segment by Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Erythropoietin Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Erythropoietin Segment by Application
Anemia
Kidney Disorders
Others
Erythropoietin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erythropoietin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erythropoietin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erythropoietin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Erythropoietin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erythropoietin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erythropoietin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Erythropoietin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin-alfa
- Others
Applications
- Anemia
- Kidney Disorders
- Others
Companies covered
- Amgen
- Johnson & Johnson
- Roche
- Galenica
- Emcure
- Kyowa Hakko Kirin
- 3SBio
- Biocon
- LG Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Erythropoietin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Erythropoietin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Erythropoietin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Erythropoietin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Erythropoietin Market Dynamics
- 2.1 Erythropoietin Industry Trends
- 2.2 Erythropoietin Industry Drivers
- 2.3 Erythropoietin Industry Opportunities and Challenges
- 2.4 Erythropoietin Industry Restraints
3 Erythropoietin Market by Manufacturers
- 3.1 Global Erythropoietin Revenue by Manufacturers (2021-2026)
- 3.2 Global Erythropoietin Sales by Manufacturers (2021-2026)
- 3.3 Global Erythropoietin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Erythropoietin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Erythropoietin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Erythropoietin Manufacturers, Product Type & Application
- 3.7 Global Erythropoietin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Erythropoietin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Erythropoietin Players Market Share by Revenue in 2025
- 3.8.3 2025 Erythropoietin Tier 1, Tier 2, and Tier 3
4 Erythropoietin Market by Type
- 4.1 Erythropoietin Type Introduction
- 4.1.1 Epoetin-alfa
- 4.1.2 Epoetin-beta
- 4.1.3 Darbepoetin-alfa
- 4.1.4 Others
- 4.2 Global Erythropoietin Sales by Type
- 4.2.1 Global Erythropoietin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Erythropoietin Sales by Type (2021-2032)
- 4.2.3 Global Erythropoietin Sales Market Share by Type (2021-2032)
- 4.3 Global Erythropoietin Revenue by Type
- 4.3.1 Global Erythropoietin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Erythropoietin Revenue by Type (2021-2032)
- 4.3.3 Global Erythropoietin Revenue Market Share by Type (2021-2032)
5 Erythropoietin Market by Application
- 5.1 Erythropoietin Application Introduction
- 5.1.1 Anemia
- 5.1.2 Kidney Disorders
- 5.1.3 Others
- 5.2 Global Erythropoietin Sales by Application
- 5.2.1 Global Erythropoietin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Erythropoietin Sales by Application (2021-2032)
- 5.2.3 Global Erythropoietin Sales Market Share by Application (2021-2032)
- 5.3 Global Erythropoietin Revenue by Application
- 5.3.1 Global Erythropoietin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Erythropoietin Revenue by Application (2021-2032)
- 5.3.3 Global Erythropoietin Revenue Market Share by Application (2021-2032)
6 Global Erythropoietin Sales by Region
- 6.1 Global Erythropoietin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Erythropoietin Sales by Region (2021-2032)
- 6.2.1 Global Erythropoietin Sales by Region (2021-2026)
- 6.2.2 Global Erythropoietin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Erythropoietin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Erythropoietin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Erythropoietin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Erythropoietin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Erythropoietin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Erythropoietin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Erythropoietin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Erythropoietin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Erythropoietin Revenue by Region
- 7.1 Global Erythropoietin Revenue by Region
- 7.1.1 Global Erythropoietin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Erythropoietin Revenue by Region (2021-2026)
- 7.1.3 Global Erythropoietin Revenue by Region (2027-2032)
- 7.1.4 Global Erythropoietin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Erythropoietin Revenue (2021-2032)
- 7.2.2 North America Erythropoietin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Erythropoietin Revenue (2021-2032)
- 7.3.2 Europe Erythropoietin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Erythropoietin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Erythropoietin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Erythropoietin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Erythropoietin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Amgen
- 8.1.1 Amgen Company Information
- 8.1.2 Amgen Business Overview
- 8.1.3 Amgen Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Amgen Erythropoietin Product Portfolio
- 8.1.5 Amgen Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Erythropoietin Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Roche
- 8.3.1 Roche Company Information
- 8.3.2 Roche Business Overview
- 8.3.3 Roche Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Roche Erythropoietin Product Portfolio
- 8.3.5 Roche Recent Developments
- 8.4 Galenica
- 8.4.1 Galenica Company Information
- 8.4.2 Galenica Business Overview
- 8.4.3 Galenica Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Galenica Erythropoietin Product Portfolio
- 8.4.5 Galenica Recent Developments
- 8.5 Emcure
- 8.5.1 Emcure Company Information
- 8.5.2 Emcure Business Overview
- 8.5.3 Emcure Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Emcure Erythropoietin Product Portfolio
- 8.5.5 Emcure Recent Developments
- 8.6 Kyowa Hakko Kirin
- 8.6.1 Kyowa Hakko Kirin Company Information
- 8.6.2 Kyowa Hakko Kirin Business Overview
- 8.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Kyowa Hakko Kirin Erythropoietin Product Portfolio
- 8.6.5 Kyowa Hakko Kirin Recent Developments
- 8.7 3SBio
- 8.7.1 3SBio Company Information
- 8.7.2 3SBio Business Overview
- 8.7.3 3SBio Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 3SBio Erythropoietin Product Portfolio
- 8.7.5 3SBio Recent Developments
- 8.8 Biocon
- 8.8.1 Biocon Company Information
- 8.8.2 Biocon Business Overview
- 8.8.3 Biocon Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Biocon Erythropoietin Product Portfolio
- 8.8.5 Biocon Recent Developments
- 8.9 LG Life Sciences
- 8.9.1 LG Life Sciences Company Information
- 8.9.2 LG Life Sciences Business Overview
- 8.9.3 LG Life Sciences Erythropoietin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 LG Life Sciences Erythropoietin Product Portfolio
- 8.9.5 LG Life Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Erythropoietin Value Chain Analysis
- 9.1.1 Erythropoietin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Erythropoietin Production Mode & Process
- 9.2 Erythropoietin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Erythropoietin Distributors
- 9.2.3 Erythropoietin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst